Journal
IMMUNOLOGY LETTERS
Volume 177, Issue -, Pages 6-15Publisher
ELSEVIER
DOI: 10.1016/j.imlet.2016.06.006
Keywords
Chemokine receptors; CXCR4; CXCL12; WHIM syndrome; Immunity; Signaling pathway
Categories
Funding
- European Union [602363]
- ERC [322823]
- European Research Council (ERC) [322823] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Chemokines and chemokine receptors regulate multiple processes such morphogenesis, angiogenesis and immune responses. Among the chemokine receptors, CXCR4 stands out for its pleiotropic roles as well as for its involvement in several pathological conditions, including immune diseases, viral infections and cancer. For these reasons, CXCR4 represents a crucial target in drug development. In this review, we discuss of CXCR4 receptor properties and signaling in health and diseases, focusing on the WHIM syndrome, an inherited immunodeficiency caused by mutations of the CXCR4 gene. (C) 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available